Literature DB >> 15717885

Hepatitis C virus infection-related Type 1 diabetes mellitus.

L-K Chen1, Y-C Chou, S-T Tsai, S-J Hwang, S-D Lee.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) has been associated with Type 2 diabetes mellitus, and many other viral infections have been associated with Type 1 diabetes mellitus (Type 1 DM). An association between HCV and Type 1 DM, however, has never been reported. We report the case of a 66-year-old man who developed Type 1 DM 1 year after a blood transfusion-related HCV infection. Testing of serum specimens obtained in the weeks following blood transfusion demonstrated evidence of both acute HCV infection and development of Type 1 DM-related autoantibodies. CASE REPORT: A 66-year-old Taiwanese male received blood transfusions during coronary artery bypass surgery in 1987. Serum specimens, obtained as part of a study on post-transfusion hepatitis, demonstrated that the patient had no evidence of hepatitis C prior to transfusion, but developed acute HCV infection after transfusion. One year later, the patient, who had no personal or family history of diabetes, presented with diabetic ketoacidosis, and tests for C-peptide confirmed that he had Type 1 DM. Testing of pre- and post-operative serum specimens demonstrated that the patient developed positive tests for islet cell and glutamic acid decarboxylase antibodies 4 weeks after transfusion, concurrent with the development of acute HCV infection.
CONCLUSIONS: The simultaneous development of HCV infection and diabetes-related autoantibodies suggest a relationship between HCV and Type 1 DM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717885     DOI: 10.1111/j.1464-5491.2005.01412.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  9 in total

Review 1.  Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Dilia Giuggioli; Andrea Di Domenicantonio; Ilaria Ruffilli; Alda Corrado; Silvia Fabiani; Santino Marchi; Clodoveo Ferri; Ele Ferrannini; Poupak Fallahi
Journal:  World J Diabetes       Date:  2014-10-15

Review 2.  Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis.

Authors:  Metin Basaranoglu; Gökcen Basaranoglu
Journal:  World J Gastroenterol       Date:  2011-09-28       Impact factor: 5.742

3.  Type 1 Diabetes Mellitus Associated with Pegylated Interferon-α Plus Ribavirin Treatment for Chronic Hepatitis C: Case Report and Literature Review.

Authors:  Reiko Oka; Naoki Hiroi; Rika Shigemitsu; Mariko Sue; Yasuo Oshima; Mayumi Yoshida-Hiroi
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2011-08-23

4.  Clinical & immunological profile of newly diagnosed patients with youth onset diabetes mellitus.

Authors:  D K Dhanwal; S Agarwal; S Garg; P Agarwal
Journal:  Indian J Med Res       Date:  2014-09       Impact factor: 2.375

5.  Hepatitis C virus infection in a child with autoimmune polyendocrine syndrome type 2: a case report.

Authors:  Kotb Abbass Metwalley; Hekma Saad Farghaly
Journal:  J Med Case Rep       Date:  2012-07-27

6.  The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action.

Authors:  S C L Gough; M J Simmonds
Journal:  Curr Genomics       Date:  2007-11       Impact factor: 2.236

Review 7.  Diabetes and Hepatitis C: A Two-Way Association.

Authors:  Sara Salehi Hammerstad; Shira Frankel Grock; Hanna J Lee; Alia Hasham; Nina Sundaram; Yaron Tomer
Journal:  Front Endocrinol (Lausanne)       Date:  2015-09-14       Impact factor: 5.555

8.  Network-based study reveals potential infection pathways of hepatitis-C leading to various diseases.

Authors:  Anirban Mukhopadhyay; Ujjwal Maulik
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

9.  HCV Genotype Has No Influence on the Incidence of Diabetes-EpiTer Multicentre Study.

Authors:  Paweł Rajewski; Dorota Zarębska-Michaluk; Ewa Janczewska; Andrzej Gietka; Włodzimierz Mazur; Magdalena Tudrujek-Zdunek; Krzysztof Tomasiewicz; Teresa Belica-Wdowik; Barbara Baka-Ćwierz; Dorota Dybowska; Waldemar Halota; Beata Lorenc; Marek Sitko; Aleksander Garlicki; Hanna Berak; Andrzej Horban; Iwona Orłowska; Krzysztof Simon; Łukasz Socha; Marta Wawrzynowicz-Syczewska; Jerzy Jaroszewicz; Zbigniew Deroń; Agnieszka Czauż-Andrzejuk; Jolanta Citko; Rafał Krygier; Anna Piekarska; Łukasz Laurans; Witold Dobracki; Jolanta Białkowska; Olga Tronina; Magdalena Wietlicka-Piszcz; Małgorzata Pawłowska; Robert Flisiak
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.